Brief: Labcorp - Will Begin Testing For Monkeypox Using U.S. CDC's Orthopoxvirus Test
July 6 (Reuters) - Laboratory Corporation of America Holdings LH.N :
* LABCORP - WILL BEGIN TESTING FOR MONKEYPOX USING U.S. CENTERS FOR DISEASE
CONTROL AND PREVENTION'S (CDC) ORTHOPOXVIRUS TEST
* LABCORP - WILL INITIALLY PERFORM ALL MONKEYPOX TESTING IN MAIN NORTH
CAROLINA
LAB & HAVE CAPACITY TO EXPAND TO LOCATIONS NATIONWIDE IF NEED ARISES
Source text for Eikon: ID:nBwJ50y6a
Further company coverage: LH.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laboratory of America Holdings
See all newsBrief: Labcorp To Announce Second Quarter 2026 Financial Results On July 30, 2026
Brief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health